本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.74
-0.0400-2.25%
成交量:130.19萬
成交額:226.44萬
市值:6.00億
市盈率:-2.67
高:1.80
開:1.80
低:1.72
收:1.78
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.62億
量比:0.44
換手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.38
市盈率(LYR):-2.01

資料載入中...

2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/27

重要事件披露

Current report, item 8.01
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/20

重要事件披露

Current report, item 5.02
2019/11/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, item 1.01
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/08/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/07

重要事件披露

Current report, items 2.02 and 9.01
2019/07/30

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/22

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/22

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/01

持股變動聲明

Statement of changes in beneficial ownership of securities